Cornwall, Ont. woman fighting for access to life-changing drug
Chanelle LaFlèche has been waiting her entire life for a drug that can treat her rare form of cystic fibrosis.
Finally, it exists, but LaFlèche cannot access it, and neither can any of the 10 per cent of Canadians living with cystic fibrosis who do not have the most common gene mutation.
Doctors diagnosed LaFlèche at age seven, but it was after she turned 18 that the disease worsened dramatically.
Air and blood flow in her right lung dropped to just five per cent and in January surgeons removed it in a pneumonectomy. Her remaining lung only functions at roughly 30 per cent and is at risk of dropping further, but the disease isn’t confined to her lungs.
“Most people think it’s just lungs. It’s digestive, it’s sinus it’s lungs, my hearts been affected, my growth, my liver is being affected from all the medications,” LaFlèche said.
In 2019, the American government approved a drug called Trikafta, which targets the specific genetic mutations that cause cystic fibrosis and attempts to eliminate the buildup of mucus that infects and damages organs.
The American Federal Drug Administration approved the drug for those living with at least one F580del mutation, roughly 90 per cent of CF patients based on clinical studies, and extended it to those living with a number of other mutations, against which the medication proved effective through in vitro data.
Health Canada has only approved its use for those with at least one F580del mutation.
“The fact that people a few kilometres away are on it, if I was a few kilometres across the bridge I would be on it, but – it’s ridiculous,” LaFlèche said.
Health Canada is reviewing expanding the use of Trikafta and clinical trials are currently underway, but LaFlèche’s doctor says she needs treatment now.
They appealed to Health Canada under a Special Access request but a spokesperson says the request doesn’t apply, writing “this would not apply to individual indications of an authorized medication as it only applied to unapproved products.”
Health Canada recommends her doctor prescribe the medication ‘off-label,’ or outside of the authorized indicated use, something experts say is common when treating rare diseases but frequently prohibitively expensive and unlikely to be covered by provincial insurance.
“Most provincial insurance, most private insurance will say if it’s not ‘on-label’ – there’s not a clear indication – we will not cover it. Even if we know it works, even if it’s covered in other countries, even if it’s just an extension,” Durhane Wong-Reiger, President and CEO of the Canadian Organization for Rare Disorders said.
“We think it’s an obstacle in many drug plans, they’re just looking for a way of getting out of it.”
For LaFlèche and her family it would mean covering the more than $308,000-per-year drug out-of-pocket.
“If I need to sell my house, I will do it. Powerless for me, I’m getting there but I’m not there yet because I’m going to do what I need to do, I’ll make it friggin’ happen. I will,” LaFlèche’s mother Céline said.
In a statement, the Ontario Health Ministry says, “coverage for Trikafta is consistent with Health Canada product labelling,” meaning LaFlèche would not be covered.
She can make an Exceptional Access Program request but the province says those requests are reviewed against “established clinical criteria.”
A list of the drug criteria for Trikafta on the province’s website cites the main F508del genetic mutation as a requirement.
Wong-Reiger says Ontario needs to do more when considering exceptional access requests, particularly when the people involved belong to small patient populations that can easily fall outside the guidelines due to the relative rarity of their diseases.
“Quebec makes it, other countries make it; to be able to look at the individual patient, how well do you fit the existing guidelines, what is the likelihood this will work for you,” Wong-Reiger said. “It’s a matter of being able to provide some flexibility, especially when we’re talking about life-changing, life-saving kind of therapies.”
“It’s such an easy fix for them, it’s such an easy fix that allows her to live,” Céline LaFlèche said.
CTVNews.ca Top Stories
DEVELOPING Alberta's request for federal assistance approved after fast-moving wildfire hit Jasper National Park: Trudeau
Prime Minister Justin Trudeau announced on social media that Ottawa has approved Alberta's request for federal assistance after a fast-moving wildfire hit Jasper National Park and its townsite late Wednesday.
Loblaw, George Weston to settle class action over bread price-fixing for $500 million
Loblaw Cos. Ltd. and its parent company George Weston Ltd. say they have agreed to pay $500-million to settle a class-action lawsuit regarding their involvement in an alleged bread price-fixing scheme.
EXCLUSIVE One address, 76 foreign currency dealers: Inside Canada's money service business 'clusters'
An IJF and CTV News investigation has found dozens of cases across Canada where multiple money services businesses (MSBs) are incorporated at the same address, sometimes without the knowledge or consent of the location's actual occupant. One money laundering expert calls it an 'abuse of the system.'
U.K. police officer suspended after video appears to show a man being kicked in head
A British police officer was suspended from all duties Thursday after a video was posted on social media that appeared to show an officer kicking and stamping on the head of a man lying on the floor of a terminal at Manchester Airport.
'I'm so broke': Two Toronto women speak out after losing $76,000 in romance scam
Two women from the Toronto area are speaking out after losing thousands of dollars to a romance scam, including a single mother who lost $62,000.
Barrie-Innisfil MPP 'blacked-out' and crashed car into window of child care centre
Staff at a Barrie child care centre say they are frustrated by what they call a local MPP's inadequate response after a car crashed through a window in one of the toddler rooms.
Norad intercepts Russian and Chinese bombers operating together near Alaska in apparent first
The North American Aerospace Defence Command (Norad) intercepted two Russian and two Chinese bombers flying near Alaska Wednesday in what appears to be the first time the two countries have been intercepted while operating together.
Biden explains why he ended re-election bid in Oval Office address
U.S. President Joe Biden on Wednesday delivered a solemn call to voters to defend the country's democracy as he laid out in an Oval Office address his decision to drop his bid for reelection and throw his support behind Vice President Kamala Harris.
Jasper mayor says alert system to be reviewed after message 'glitch'
More than 25,000 people have been displaced from Jasper National Park since wildfires started to threaten the picturesque corner of Alberta Rockies on Monday, but the mayor of its namesake municipality says not everyone received an evacuation alert when it was sent out.